|
Real-time Estimate
Cboe BZX
02:58:38 2026-10-21 pm EDT
|
5-day change | 1st Jan Change | ||
| 438.08 USD | -0.20% |
|
+2.71% | +33.71% |
| 05:24am | Barclays Adjusts Price Target on Amgen to $400 From $380 | MT |
| 02:28am | Positive Results for an AstraZeneca and Amgen Product |  |
| Market Cap | 237B 211B 196B 177B 334B 22,394B 338B 2,347B 921B 11,771B 890B 872B 37,509B | P/E 2026 * |
27.9x | P/E 2027 * | 24.9x |
|---|---|---|---|---|---|
| Enterprise Value | 279B 248B 230B 208B 392B 26,296B 397B 2,756B 1,082B 13,822B 1,045B 1,024B 44,046B | EV / Sales 2026 * |
7.15x | EV / Sales 2027 * | 6.76x |
| Free-Float |
99.77% | Yield 2026 * |
2.3% | Yield 2027 * | 2.43% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMGN | Delayed | |
CBOE
| AMGN | Real-time | |
|
Tradegate
| AMG | Real-time | |
|
Mexican S.E.
| AMGN * | End-of-day quote | |
|
Xetra
| AMG | Delayed | |
|
Boerse Muenchen
| AMG | Real-time | |
|
Deutsche Boerse AG
| AMG | Delayed | |
|
London S.E.
| 0R0T | Delayed | |
|
CBOE
| 0R0T | Real-time | |
|
Börse Stuttgart
| AMG | Delayed | |
|
Borsa Italiana
| 1AMGN | End-of-day quote | |
|
Berne S.E.
| 000907582 | End-of-day quote | |
|
Wiener Boerse
| AMGN | End-of-day quote | |
|
Santiago S.E.
| AMGN | End-of-day quote | |
|
Santiago S.E.
| AMGNCL | End-of-day quote | |
|
CBOE
| Real-time |
Last Transcript: Amgen Inc.
| 1 day | -0.32% | ||
| 1 week | +2.66% | ||
| Current month | +3.78% | ||
| 1 month | +11.27% | ||
| 3 months | +19.45% | ||
| 6 months | +26.85% | ||
| Current year | +33.65% |
| 1 week | 424.74 |  | 441.76 |
| 1 month | 396.01 | | 441.76 |
| Current year | 318.21 | | 447.03 |
| 1 year | 288 | | 447.03 |
| 3 years | 249.7 | | 447.03 |
| 5 years | 198.64 | | 447.03 |
| 10 years | 133.64 | | 447.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 2012-04-30 |
| Director of Finance/CFO | 62 | 2010-05-12 | |
Paul Burton
CTO | Chief Tech/Sci/R&D Officer | 57 | 2023-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 2012-12-31 |
Tyler Jacks
BRD | Director/Board Member | 65 | 2011-12-31 |
Robert Eckert
BRD | Director/Board Member | 71 | 2011-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/1/26 | Other | Chief Financial Officer | 34,061 | 0.0063% | ||
| 8/13/26 | Exercice | Executive/Senior Manager | 3,756 | 0.0007% | ||
| 8/7/26 | Free | Director | 85 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.31% | +2.66% | +45.27% | +60.21% | 237B | |
| -0.76% | +5.31% | +59.20% | +120.75% | 1,144B | |
| -1.09% | +0.84% | +33.44% | +69.13% | 625B | |
| -1.94% | -0.02% | +22.48% | +95.82% | 511B | |
| +0.54% | +5.69% | +39.60% | +65.02% | 377B | |
| +0.43% | +0.85% | +69.63% | +43.81% | 366B | |
| +0.30% | +3.44% | +21.35% | +50.15% | 291B | |
| -0.03% | +2.55% | +1.12% | +24.89% | 262B | |
| -2.21% | -0.10% | +23.62% | +97.77% | 194B | |
| +0.19% | +2.25% | -26.27% | -61.64% | 174B | |
| Average | -0.48% | +5.86% | +28.94% | +56.59% | 418.16B | |
| Weighted average by Cap. | -0.62% | +6.70% | +37.74% | +75.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.97B 34.72B 32.15B 29.09B 54.81B 3,677B 55.46B 385B 151B 1,933B 146B 143B 6,159B | 40.36B 35.96B 33.29B 30.13B 56.76B 3,808B 57.44B 399B 157B 2,002B 151B 148B 6,379B |
| Net income | 8.54B 7.61B 7.05B 6.38B 12.01B 806B 12.16B 84.48B 33.15B 424B 32.04B 31.37B 1,350B | 9.43B 8.4B 7.78B 7.04B 13.26B 889B 13.42B 93.24B 36.59B 468B 35.36B 34.62B 1,490B |
| Net Debt | 41.36B 36.85B 34.12B 30.88B 58.17B 3,903B 58.86B 409B 161B 2,051B 155B 152B 6,537B | 35.3B 31.46B 29.13B 26.36B 49.66B 3,331B 50.25B 349B 137B 1,751B 132B 130B 5,580B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-21 | $437.62 | -0.30% | 915,642 |
| 26-10-20 | $438.94 | +3.29% | 2,217,227 |
| 26-10-19 | $424.94 | -1.75% | 2,682,830 |
| 26-10-16 | $432.49 | -0.35% | 2,567,330 |
| 26-10-15 | $434.03 | +1.86% | 4,625,784 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
Select your edition
All financial news and data tailored to specific country editions
